Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 0.16 | 8.68 | 3.91 | 3.23 |
Cash Equivalents | 8.44 | 0.05 | 42.47 | 194.46 |
Short Term Investments | 7.42 | 0.98 | 1.17 | - |
Cashand Short Term Investments | 16.02 | 9.71 | 47.55 | 197.69 |
Accounts Receivable- Trade Net | 348.52 | 536.99 | 489.67 | 483.87 |
Total Receivables Net | 348.86 | 606.13 | 602.05 | 542.80 |
Total Inventory | 359.70 | 561.30 | 579.96 | 300.48 |
Other Current Assets Total | 76.17 | 0.16 | 0.87 | 0.85 |
Total Current Assets | 800.75 | 1,187.54 | 1,239.28 | 1,057.63 |
Property/ Plant/ Equipment Total- Net | 1,114.22 | 1,159.05 | 1,137.42 | 999.20 |
Goodwill Net | 365.09 | 365.09 | 365.09 | 365.09 |
Intangibles Net | 42.56 | 54.35 | 67.94 | 79.98 |
Long Term Investments | 4.09 | 25.64 | 25.01 | 25.71 |
Note Receivable- Long Term | 3.62 | 5.92 | 33.92 | 40.92 |
Other Long Term Assets Total | 20.63 | 101.69 | 76.30 | 45.05 |
Total Assets | 2,350.96 | 2,899.28 | 2,944.96 | 2,613.58 |
Accounts Payable | 313.01 | 305.86 | 275.99 | 309.30 |
Accrued Expenses | 1.97 | 4.28 | 4.36 | 2.31 |
Current Portof LT Debt/ Capital Leases | 894.06 | 117.80 | 133.73 | 93.25 |
Other Currentliabilities Total | 33.81 | 24.39 | 39.44 | 23.01 |
Total Current Liabilities | 1,242.85 | 1,101.13 | 1,063.42 | 788.75 |
Long Term Debt | 105.83 | 235.10 | 283.04 | 154.83 |
Capital Lease Obligations | 11.61 | 11.15 | 10.70 | 11.77 |
Total Long Term Debt | 117.44 | 246.25 | 293.74 | 166.60 |
Total Debt | 1,011.50 | 1,012.85 | 1,037.37 | 620.73 |
Minority Interest | 2.67 | 2.24 | 2.31 | 4.24 |
Other Liabilities Total | 54.09 | 49.45 | 60.62 | 65.47 |
Total Liabilities | 1,417.05 | 1,399.07 | 1,420.09 | 1,025.06 |
Common Stock Total | 36.00 | 36.00 | 36.00 | 35.92 |
Retained Earnings( Accumulated Deficit) | 897.91 | 250.37 | 274.73 | 342.65 |
Total Equity | 933.91 | 1,500.21 | 1,524.87 | 1,588.52 |
Total Liabilities Shareholders' Equity | 2,350.96 | 2,899.28 | 2,944.96 | 2,613.58 |
Total Common Shares Outstanding | 3.91 | 3.60 | 3.60 | 3.59 |
Tangible Book Valueper Share Common Eq | 134.72 | 300.25 | 303.32 | 318.25 |
Prepaid Expenses | - | 10.24 | 8.85 | 15.81 |
Property/ Plant/ Equipment Total- Gross | - | 1,604.53 | 1,499.59 | 1,266.30 |
Accumulated Depreciation Total | - | -445.48 | -362.17 | -267.10 |
Notes Payable/ Short Term Debt | - | 648.80 | 609.90 | 360.88 |
Additional Paid- In Capital | - | 1,216.03 | 1,216.03 | 1,211.72 |
Other Equity Total | - | -2.19 | -1.89 | -1.77 |
Deferred Income Tax | - | - | - | 0.00 |
Solara Active Pharma Sciences Dividend Solara Active Pharma Sciences Bonus Solara Active Pharma Sciences News Solara Active Pharma Sciences AGM Solara Active Pharma Sciences Rights Solara Active Pharma Sciences Splits Solara Active Pharma Sciences Board Meetings Solara Active Pharma Sciences Key Metrics Solara Active Pharma Sciences Shareholdings Solara Active Pharma Sciences Profit Loss Solara Active Pharma Sciences Cashflow Solara Active Pharma Sciences Q1 Results Solara Active Pharma Sciences Q2 Results Solara Active Pharma Sciences Q3 Results Solara Active Pharma Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks